A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT06613360

Public ClinicalTrials.gov record NCT06613360. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 24, 2026, 3:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b, Open-label, Pilot Study of CLN-978 for the Treatment of Moderate to Severe Systemic Lupus Erythematosus (SLE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 1b, open-label study of CLN-978 administered subcutaneously in patients with Moderate to Severe Systemic Lupus Erythematosus (SLE).

Study identification

NCT ID: NCT06613360
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Cullinan Therapeutics Inc.; Industry
Enrollment: 24 participants

Conditions and interventions

Conditions

Interventions

CLN-978 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 21, 2025 (Actual)
Primary completion: Dec 2026 (Estimated)
Completion: Dec 2027 (Estimated)
Last update posted: Oct 22, 2026

2025 – 2027

United States locations

U.S. sites: 12
U.S. states: 8
U.S. cities: 11

Facility	City	State	ZIP	Site status
AARA Clinical Research	Avondale	Arizona	85392	Recruiting
AARA Clinical Research	Tucson	Arizona	85704	Recruiting
Omega Research Group	Orlando	Florida	32808	Recruiting
University of Iowa	Iowa City	Iowa	52242	Recruiting
Boston Children's Hospital	Boston	Massachusetts	02115	Recruiting
NYU Grossman School of Medicine	New York	New York	10016	Recruiting
Columbia University Medical Center	New York	New York	10032	Withdrawn
University of Rochester Medical Center	Rochester	New York	14642	Recruiting
Regional One Health	Memphis	Tennessee	38103	Recruiting
Stryde Research	Plano	Texas	75093	Recruiting
Tranquil Clinical Research	Webster	Texas	77598	Recruiting
Intermountain Health	Salt Lake City	Utah	84101	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06613360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 22, 2026 · Synced Oct 24, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06613360 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →